TY - JOUR
T1 - Oncologic and Safety Outcomes for Retrograde and Antegrade Endoscopic Surgeries for Upper Tract Urothelial Carcinoma
T2 - A Systematic Review and Meta-analysis
AU - Laukhtina, Ekaterina
AU - Kawada, Tatsushi
AU - Quhal, Fahad
AU - Yanagisawa, Takafumi
AU - Rajwa, Pawel
AU - von Deimling, Markus
AU - Pallauf, Maximilian
AU - Bianchi, Alberto
AU - Majdoub, Muhammad
AU - Enikeev, Dmitry
AU - Fajkovic, Harun
AU - Teoh, Jeremy Yuen Chun
AU - Rouprêt, Morgan
AU - Gontero, Paolo
AU - Shariat, Shahrokh F.
N1 - Publisher Copyright:
© 2022 The Authors
PY - 2023/3
Y1 - 2023/3
N2 - The aim of this study was to identify and summarize available data on oncologic and safety outcomes for retrograde versus antegrade endoscopic surgery in patients with upper tract urothelial carcinoma (UTUC). We systematically searched studies reporting on endoscopic surgery in patients with UTUC. The primary outcome of interest was oncologic control, including bladder and upper urinary tract recurrences. The secondary outcomes were any-grade and major complications. Twenty studies comprising 1091 patients were included in our analysis. The pooled bladder recurrence rate was 35% (95% confidence interval [CI] 28.0–42.3%; I2 = 48%) after retrograde endoscopic surgery and 17.7% (95% CI 6.5–32.1%; I2 = 29%) after antegrade endoscopic surgery. The pooled upper urinary tract recurrence rate was 56.4% (95% CI 41.2–70.9; I2 = 93%) after retrograde endoscopic surgery and 36.2% (95% CI 25.5–47.6%; I2 = 57%) after antegrade endoscopic surgery. The pooled complication rate was 12.5% (95% CI 0.8–32.8%; I2 = 94%) for any-grade complications and 6.6% (95% CI 0.1–19.1%; I2 = 89%) for major complications in the retrograde endoscopic cohort. In summary, our analyses suggest promising oncologic benefits of antegrade kidney-sparing surgery in terms of bladder and upper urinary tract recurrence rates in UTUC. Retrograde endoscopic surgery is a safe procedure with a minimal risk of complications and acceptable oncologic outcomes. Research should address the hypothesis that endoscopic antegrade surgery can be a safe and effective alternative for well-selected patients. Patient summary: One of the surgical options for treatment of cancer of the upper urinary tract is removal of the tumor through a small telescope called an endoscope. The endoscope can be inserted via the urethra (called a retrograde approach) or through a small incision in the skin (antegrade approach). Our review shows that the antegrade approach seems to provide acceptable cancer control rates. Further research could help to identify the role for endoscope surgery in cancer of the upper urinary tract.
AB - The aim of this study was to identify and summarize available data on oncologic and safety outcomes for retrograde versus antegrade endoscopic surgery in patients with upper tract urothelial carcinoma (UTUC). We systematically searched studies reporting on endoscopic surgery in patients with UTUC. The primary outcome of interest was oncologic control, including bladder and upper urinary tract recurrences. The secondary outcomes were any-grade and major complications. Twenty studies comprising 1091 patients were included in our analysis. The pooled bladder recurrence rate was 35% (95% confidence interval [CI] 28.0–42.3%; I2 = 48%) after retrograde endoscopic surgery and 17.7% (95% CI 6.5–32.1%; I2 = 29%) after antegrade endoscopic surgery. The pooled upper urinary tract recurrence rate was 56.4% (95% CI 41.2–70.9; I2 = 93%) after retrograde endoscopic surgery and 36.2% (95% CI 25.5–47.6%; I2 = 57%) after antegrade endoscopic surgery. The pooled complication rate was 12.5% (95% CI 0.8–32.8%; I2 = 94%) for any-grade complications and 6.6% (95% CI 0.1–19.1%; I2 = 89%) for major complications in the retrograde endoscopic cohort. In summary, our analyses suggest promising oncologic benefits of antegrade kidney-sparing surgery in terms of bladder and upper urinary tract recurrence rates in UTUC. Retrograde endoscopic surgery is a safe procedure with a minimal risk of complications and acceptable oncologic outcomes. Research should address the hypothesis that endoscopic antegrade surgery can be a safe and effective alternative for well-selected patients. Patient summary: One of the surgical options for treatment of cancer of the upper urinary tract is removal of the tumor through a small telescope called an endoscope. The endoscope can be inserted via the urethra (called a retrograde approach) or through a small incision in the skin (antegrade approach). Our review shows that the antegrade approach seems to provide acceptable cancer control rates. Further research could help to identify the role for endoscope surgery in cancer of the upper urinary tract.
KW - Antegrade
KW - Endoscopic surgery
KW - Kidney-sparing surgery
KW - Retrograde
KW - Upper tract urothelial carcinoma
UR - http://www.scopus.com/inward/record.url?scp=85142488303&partnerID=8YFLogxK
U2 - 10.1016/j.euf.2022.11.014
DO - 10.1016/j.euf.2022.11.014
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 36428210
AN - SCOPUS:85142488303
SN - 2405-4569
VL - 9
SP - 258
EP - 263
JO - European Urology Focus
JF - European Urology Focus
IS - 2
ER -